Company Filing History:
Years Active: 2018
Title: Mika Nishihara: Innovator in Glycosylated Polypeptides
Introduction
Mika Nishihara is a prominent inventor based in Amagasaki, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of glycosylated polypeptides. Her innovative work has the potential to impact various therapeutic applications.
Latest Patents
Mika Nishihara holds a patent for a polypeptide having sialylated sugar chains attached thereto. The patent, titled "Polypeptide having sialylated sugar chains attached thereto," focuses on providing a polypeptide with interferon β activity that is glycosylated with highly uniform sialylated sugar chains. The invention includes a glycosylated polypeptide selected from several specific amino acid sequences and analogs, ensuring that all non-reducing terminals of the sugar chain are sialylated. She has 1 patent to her name.
Career Highlights
Mika Nishihara is associated with Glytech, Inc., where she continues to advance her research in glycosylation and its applications in medicine. Her work is characterized by a commitment to innovation and excellence in the field of biotechnology.
Collaborations
Mika collaborates with notable colleagues, including Masaki Ohuchi and Katsunari Tezuka. Their combined expertise fosters a dynamic research environment that encourages groundbreaking discoveries.
Conclusion
Mika Nishihara is a trailblazer in the field of glycosylated polypeptides, with a focus on enhancing therapeutic efficacy through innovative biotechnology. Her contributions are paving the way for future advancements in medical treatments.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.